Collagen/heparin sulfate scaffolds fabricated by a 3D bioprinter improved mechanical properties and neurological function after spinal cord injury in rats

2017 ◽  
Vol 105 (5) ◽  
pp. 1324-1332 ◽  
Author(s):  
Chong Chen ◽  
Ming-liang Zhao ◽  
Ren-kun Zhang ◽  
Gang Lu ◽  
Chang-yu Zhao ◽  
...  
2012 ◽  
Vol 46 (2) ◽  
pp. 237-245 ◽  
Author(s):  
Joanna H.L. Diong ◽  
Robert D. Herbert ◽  
Lisa A. Harvey ◽  
Li Khim Kwah ◽  
Jillian L. Clarke ◽  
...  

2008 ◽  
Vol 89 (11) ◽  
pp. e13-e14
Author(s):  
Ji Woong Park ◽  
Ki-Un Jang ◽  
Hyuck Lee ◽  
Ju Yun Lee ◽  
Yang Gyun Lee ◽  
...  

2001 ◽  
Vol 363 (1) ◽  
pp. 94-100 ◽  
Author(s):  
Toshio Suzuki ◽  
Hozumi Tatsuoka ◽  
Tanemichi Chiba ◽  
Toshihiko Sekikawa ◽  
Tetsuharu Nemoto ◽  
...  

2020 ◽  
Vol 323 ◽  
pp. 113085 ◽  
Author(s):  
Kristina A. Kigerl ◽  
Kylie Zane ◽  
Kia Adams ◽  
Matthew B. Sullivan ◽  
Phillip G. Popovich

1988 ◽  
Vol 69 (3) ◽  
pp. 399-402 ◽  
Author(s):  
Joseph M. Piepmeier ◽  
N. Ross Jenkins

✓ Sixty-nine patients with traumatic spinal cord injuries were evaluated for changes in their functional neurological status at discharge from the hospital, and at 1 year, 3 years, and 5+ years following injury. The neurological examinations were used to classify patients' spinal cord injury according to the Frankel scale. This analysis revealed that the majority of improvement in neurological function occurred within the 1st year following injury; however, changes in the patients' status continued for many years. Follow-up examinations at an average of 3 years postinjury revealed that 23.3% of the patients continued to improve, whereas 7.1% had deteriorated compared to their status at 1 year. An examination at an average of 5+ years demonstrated further improvement in 12.5%, with 5.0% showing deterioration compared to the examinations at 3 years. These results demonstrate that, in patients with spinal trauma, significant changes in neurological function continue for many years.


Neurosurgery ◽  
2001 ◽  
Vol 49 (6) ◽  
pp. 1427-1433 ◽  
Author(s):  
Jeffrey J. Legos ◽  
Kurt R. Gritman ◽  
Ronald F. Tuma ◽  
William F. Young

ABSTRACT OBJECTIVE We previously demonstrated that administration of 7.5% hypertonic saline (HS) significantly improved spinal cord blood flow and neurological outcomes after spinal cord injury. The aim of this study was to determine whether hypertonicity would enhance the effects of methylprednisolone (MP), further improving neurological function. METHODS Rat spinal cords were compressed for 10 minutes with 50 g of weight, and neurological function was assessed for 28 days, using the Basso-Beattie-Bresnahan locomotor rating scale. The control group received an intravenous injection of isotonic saline (IS) (5 ml/kg). Group 1 received an intravenous injection of 7.5% HS (5 ml/kg). Group 2 received an intravenous injection of MP (30 mg/kg) and IS (5 ml/kg). Group 3 received an intravenous injection of MP (30 mg/kg) administered with 7.5% HS (5 ml/kg). RESULTS At 24 hours after spinal cord injury, the combination of MP plus HS provided significant (P < 0.01) neurological improvements, compared with all other treatment groups. At 10 days after injury, the animals that had received MP plus HS exhibited significantly (P < 0.01) higher Basso-Beattie-Bresnahan scores, compared with the MP plus IS and control groups. The median survival time was significantly (P < 0.01) increased for the MP plus HS group (28 d), compared with the MP plus IS group (16 d). Because of the dramatic decrease in survival rates at 28 days after injury, there was a significant (P < 0.01) difference in neurological function only between the MP plus HS group and the control group. CONCLUSION The results indicate that the administration of HS may enhance the delivery of MP and prevent immunosuppression, leading to improvements in overall neurological function and survival rates after spinal cord injury.


Sign in / Sign up

Export Citation Format

Share Document